3 S Bio

15 email addresses found for 3sbio.com
{first}_{last}@3sbio.com
15 email addresses
http://3sbio.com/en/investors/press-releases/171-3sbio-inc-obtains-exclusive-licenses-to-develop-and-market-jenkems-peg-irinotecan-in-china July 7, 2016
http://3sbio.com/en/investors/press-releases/213-3sbio-signs-exclusive-patent-license-agreement-for-tanibirumab-an-anti-vegfr2-kdr-mab-with-pharmabcine July 7, 2016
http://3sbio.com/en/investors/press-releases/214-3sbio-acquires-sirton-pharmaceuticals-spa July 7, 2016
http://3sbio.com/en/investors/press-releases/246-3sbio-signs-exclusive-patent-license-agreement-for-alt-p7-an-antibody-drug-conjugate-targeting-her2-with-alteogen July 7, 2016
http://3sbio.com/en/investors/press-releases/249-3sbio-s-peg-irinotecan-wins-ind-approval-from-china-fda July 7, 2016
http://bio-medicine.org/medicine-technology-1/3sbio-signs-exclusive-patent-license-agreement-with-dinona-for-leukotuximab-39095-1 October 10, 2016
http://bio-medicine.org/medicine-technology-1/3sbio-signs-exclusive-patent-license-agreement-with-dinona-for-leukotuximab-39095-4 March 3, 2016
http://bio-medicine.org/medicine-technology-1/3sbio-signs-exclusive-patent-license-agreement-with-dinona-for-leukotuximab-39095-4/ July 7, 2015
http://biospace.com/article/releases/3sbio-inc-exclusively-licenses-pegsiticase-uricase-peg-20-to-selecta-biosciences-inc-to-develop-drug-candidate-to-treat-gout- November 11, 2017
http://biospace.com/article/releases/3sbio-inc-signs-exclusive-patent-license-agreement-for-alt-p7-an-antibody-drug-conjugate-targeting-her2-with-b-alteogen-b- November 11, 2017
http://biospace.com/article/releases/3sbio-inc-to-develop-dj5-for-progressive-renal-failure-in-adpkd-patients- November 11, 2017
http://biospace.com/news/3sbio-inc-exclusively-licenses-pegsiticase-uricase/337338 January 1, 2015
http://biospace.com/news/3sbio-inc-to-develop-dj5-for-progressive-renal/313458 April 4, 2018
http://fiercepharma.com/regulatory/3sbio-s-peg-irinotecan-wins-ind-approval-from-china-fda October 10, 2016
http://onvista.de/news/3sbio-to-develop-dj5-for-progressive-renal-failure-in-adpkd-patients-1731347 May 5, 2015
http://prnewswire.com/news-releases/3sbio-inc-exclusively-licenses-pegsiticase-uricase-peg-20-to-selecta-biosciences-to-develop-drug-candidate-to-treat-gout-263589751.html April 4, 2015
http://prnewswire.com/news-releases/3sbio-signs-exclusive-patent-license-agreement-for-alt-p7-an-antibody-drug-conjugate-targeting-her2-with-alteogen-300157641.html July 7, 2017
http://prnewswire.com/news-releases/3sbio-signs-exclusive-patent-license-agreement-with-dinona-for-leukotuximab-270411351.html April 4, 2015
http://prnewswire.com/news-releases/3sbios-peg-irinotecan-wins-ind-approval-from-china-fda-300231528.html March 3, 2017
http://prnewswire.com/news-releases/3sbio-to-develop-dj5-for-progressive-renal-failure-in-adpkd-patients-229670751.html February 2, 2015
http://3sbio.com/en/investors/press-releases/171-3sbio-inc-obtains-exclusive-licenses-to-develop-and-market-jenkems-peg-irinotecan-in-china July 7, 2016
http://3sbio.com/en/investors/press-releases/213-3sbio-signs-exclusive-patent-license-agreement-for-tanibirumab-an-anti-vegfr2-kdr-mab-with-pharmabcine July 7, 2016
http://3sbio.com/en/investors/press-releases/214-3sbio-acquires-sirton-pharmaceuticals-spa July 7, 2016
http://3sbio.com/en/investors/press-releases/246-3sbio-signs-exclusive-patent-license-agreement-for-alt-p7-an-antibody-drug-conjugate-targeting-her2-with-alteogen July 7, 2016
http://3sbio.com/en/investors/press-releases/249-3sbio-s-peg-irinotecan-wins-ind-approval-from-china-fda July 7, 2016
http://bio-medicine.org/biology-technology-1/3sbio-inc--announces-appointment-of-ernst--26-young-hua-ming-as-independent-auditor-11912-1 May 5, 2016
http://bio-medicine.org/biology-technology-1/3SBio-Inc--Announces-Appointment-of-Ernst--26-Young-Hua-Ming-as-Independent-Auditor-11912-1 April 4, 2015
http://bio-medicine.org/medicine-news-1/3sbio-inc--announces-unaudited-first-quarter-2009-results-46430-1 May 5, 2016
http://bio-medicine.org/medicine-technology-1/3sbio-signs-exclusive-patent-license-agreement-with-dinona-for-leukotuximab-39095-4 March 3, 2016
http://bio-medicine.org/medicine-technology-1/3sbio-signs-exclusive-patent-license-agreement-with-dinona-for-leukotuximab-39095-4/ July 7, 2015
http://biospace.com/article/releases/3sbio-inc-signs-exclusive-patent-license-agreement-for-alt-p7-an-antibody-drug-conjugate-targeting-her2-with-b-alteogen-b- November 11, 2017
http://fiercepharma.com/regulatory/3sbio-s-peg-irinotecan-wins-ind-approval-from-china-fda October 10, 2016
http://prnewswire.com/news-releases/3sbio-signs-exclusive-patent-license-agreement-for-alt-p7-an-antibody-drug-conjugate-targeting-her2-with-alteogen-300157641.html July 7, 2017
http://prnewswire.com/news-releases/3sbio-signs-exclusive-patent-license-agreement-for-dig-kt-a-bi-specific-mab-targeting-vegfr2-and-tie-2-with-pharmabcine-300020495.html October 10, 2017
http://prnewswire.com/news-releases/3sbio-signs-exclusive-patent-license-agreement-with-dinona-for-leukotuximab-270411351.html April 4, 2015
http://prnewswire.com/news-releases/3sbios-peg-irinotecan-wins-ind-approval-from-china-fda-300231528.html March 3, 2017
http://3sbio.com/en/contact November 11, 2016
http://3sbio.com//en/investors/overview November 11, 2016
http://3sbio.com/en/investors/overview November 11, 2016
http://3sbio.com/investor_relations/index.aspx August 8, 2018
http://3sbio.com/zh-s/investors/overview November 11, 2016
http://bio-medicine.org/biology-technology-1/3sbio-inc--announces-first-quarter-2008-results-5410-1 August 8, 2018
http://bio-medicine.org/biology-technology-1/3sbio-inc--announces-promotion-of-david-chen-as-chief-operating-officer-4088-1 August 8, 2018
http://bio-medicine.org/biology-technology-1/3sbio-inc--announces-second-quarter-2008-results-7099-1 June 6, 2018
http://bio-medicine.org/medicine-technology-1/3sbio-inc--announces-extraordinary-general-meeting-of-shareholders-31531-1 August 8, 2018
http://bio-medicine.org/medicine-technology-1/3sbio-inc--to-present-at-the-db-access-asia-conference-2012-25740-1 August 8, 2018
http://biospace.com/news/3sbio-inc-announces-extraordinary-general-meeting/291457 January 1, 2015
http://biospace.com/news/3sbio-inc-announces-shareholders-approval-of-the/298040 May 5, 2017
http://biospace.com/news/3sbio-inc-files-annual-report-on-form-20-f-for/295194 January 1, 2015
http://biospace.com/news/3sbio-inc-schedules-unaudited-second-quarter-2012/267155 August 8, 2017
http://biospace.com/news/3sbio-inc-to-present-at-the-oppenheimer-6th-annual/248697 January 1, 2015
http://bloomberg.com/article/2013-02-08/adbukmghvkxw.html August 8, 2015
http://brandunity.biz/tag/inc March 3, 2018
http://br.sys-con.com/node/2440127 August 8, 2015
http://ca.sys-con.com/node/2440127 May 5, 2017
http://it.sys-con.com/node/2440127 April 4, 2015
http://prnewswire.com/news-releases/3sbio-and-davita-collaborate-on-dialysis-clinics-in-northeastern-china-141957783.html April 4, 2015
http://prnewswire.com/news-releases/3sbio-inc-schedules-third-quarter-2010-unaudited-financial-results-105160624.html October 10, 2018
http://prnewswire.com/news-releases/3sbio-inc-schedules-unaudited-fourth-quarter-and-full-year-2011-results-138640224.html May 5, 2015
http://prnewswire.com/news-releases/3sbio-inc-schedules-unaudited-second-quarter-2012-results-162816946.html May 5, 2017
http://prnewswire.com/news-releases/3sbio-inc-schedules-unaudited-third-quarter-2012-results-173226781.html April 4, 2015
http://thestreet.com/story/11600303/1/3sbio-obtains-sfda-approval-to-join-global-phase-iii-trial-for-voclosporin.html March 3, 2017
http://thestreet.com/story/11836489/3/3sbio-inc-enters-into-merger-agreement-for-going-private-transaction.html July 7, 2017
http://thestreet.com/story/11911613/1/3sbio-inc-announces-extraordinary-general-meeting-of-shareholders.html October 10, 2016
http://uk.sys-con.com/node/2440127 August 8, 2017
http://wikinvest.com/stock/3sbio_(ssrx)/filing/6-k/2008/f5496886 August 8, 2018
http://3sbio.com/en/investors/press-releases/214-3sbio-acquires-sirton-pharmaceuticals-spa July 7, 2016
http://3sbio.com/en/investors/press-releases/246-3sbio-signs-exclusive-patent-license-agreement-for-alt-p7-an-antibody-drug-conjugate-targeting-her2-with-alteogen July 7, 2016
http://3sbio.com/en/investors/press-releases/248-3sbio-inc-announces-expansion-of-its-leadership-team July 7, 2016
http://3sbio.com/en/investors/press-releases/249-3sbio-s-peg-irinotecan-wins-ind-approval-from-china-fda July 7, 2016
http://3sbio.com/en/investors/press-releases/251-3sbio-inc-selected-as-a-constituent-of-the-msci-china-index July 7, 2016
http://bio-medicine.org/medicine-technology-1/3sbio-signs-exclusive-patent-license-agreement-with-dinona-for-leukotuximab-39095-1 October 10, 2016
http://bio-medicine.org/medicine-technology-1/3sbio-signs-exclusive-patent-license-agreement-with-dinona-for-leukotuximab-39095-4 March 3, 2016
http://bio-medicine.org/medicine-technology-1/3sbio-signs-exclusive-patent-license-agreement-with-dinona-for-leukotuximab-39095-4/ July 7, 2015
http://biospace.com/article/releases/3sbio-inc-exclusively-licenses-pegsiticase-uricase-peg-20-to-selecta-biosciences-inc-to-develop-drug-candidate-to-treat-gout- November 11, 2017
http://biospace.com/article/releases/3sbio-inc-signs-exclusive-patent-license-agreement-for-alt-p7-an-antibody-drug-conjugate-targeting-her2-with-b-alteogen-b- November 11, 2017
http://biospace.com/article/releases/3sbio-inc-to-develop-dj5-for-progressive-renal-failure-in-adpkd-patients- November 11, 2017
http://biospace.com/news/3sbio-inc-exclusively-licenses-pegsiticase-uricase/337338 January 1, 2015
http://biospace.com/news/3sbio-inc-to-develop-dj5-for-progressive-renal/313458 January 1, 2015
http://dshxww.com/finacial/fin/2017/0109/556278.html June 6, 2018
http://fiercepharma.com/financials/3sbio-inc-announces-expansion-of-its-leadership-team November 11, 2016
http://fiercepharma.com/regulatory/3sbio-s-peg-irinotecan-wins-ind-approval-from-china-fda October 10, 2016
http://hipzh.com/gsgg/20170110/3578.html March 3, 2017
http://italy953.rssing.com/chan-16318876/all_p596.html October 10, 2017
http://onvista.de/news/3sbio-to-develop-dj5-for-progressive-renal-failure-in-adpkd-patients-1731347 May 5, 2015
http://prnewswire.com/news-releases/3sbio-inc-exclusively-licenses-pegsiticase-uricase-peg-20-to-selecta-biosciences-to-develop-drug-candidate-to-treat-gout-263589751.html April 4, 2015
http://prnewswire.com/news-releases/3sbio-inc-selected-as-a-constituent-of-the-msci-china-index-300268253.html September 9, 2018
http://prnewswire.com/news-releases/3sbio-signs-exclusive-patent-license-agreement-with-dinona-for-leukotuximab-270411351.html April 4, 2015
http://prnewswire.com/news-releases/3sbios-peg-irinotecan-wins-ind-approval-from-china-fda-300231528.html March 3, 2017
http://prnewswire.com/news-releases/3sbio-to-develop-dj5-for-progressive-renal-failure-in-adpkd-patients-229670751.html February 2, 2015
http://3sbio.com/en/investors/press-releases/171-3sbio-inc-obtains-exclusive-licenses-to-develop-and-market-jenkems-peg-irinotecan-in-china July 7, 2016
http://3sbio.com/en/investors/press-releases/213-3sbio-signs-exclusive-patent-license-agreement-for-tanibirumab-an-anti-vegfr2-kdr-mab-with-pharmabcine July 7, 2016
http://3sbio.com/en/investors/press-releases/214-3sbio-acquires-sirton-pharmaceuticals-spa July 7, 2016
http://3sbio.com/en/investors/press-releases/246-3sbio-signs-exclusive-patent-license-agreement-for-alt-p7-an-antibody-drug-conjugate-targeting-her2-with-alteogen July 7, 2016
http://3sbio.com/en/investors/press-releases/249-3sbio-s-peg-irinotecan-wins-ind-approval-from-china-fda July 7, 2016
http://bio-medicine.org/medicine-technology-1/3sbio-signs-exclusive-patent-license-agreement-with-dinona-for-leukotuximab-39095-1 October 10, 2016
http://bio-medicine.org/medicine-technology-1/3sbio-signs-exclusive-patent-license-agreement-with-dinona-for-leukotuximab-39095-4 March 3, 2016
http://bio-medicine.org/medicine-technology-1/3sbio-signs-exclusive-patent-license-agreement-with-dinona-for-leukotuximab-39095-4/ July 7, 2015
http://biospace.com/article/releases/3sbio-inc-signs-exclusive-patent-license-agreement-for-alt-p7-an-antibody-drug-conjugate-targeting-her2-with-b-alteogen-b- November 11, 2017
http://fiercepharma.com/regulatory/3sbio-s-peg-irinotecan-wins-ind-approval-from-china-fda October 10, 2016
http://prnewswire.com/news-releases/3sbio-signs-exclusive-patent-license-agreement-for-alt-p7-an-antibody-drug-conjugate-targeting-her2-with-alteogen-300157641.html July 7, 2017
http://prnewswire.com/news-releases/3sbio-signs-exclusive-patent-license-agreement-for-dig-kt-a-bi-specific-mab-targeting-vegfr2-and-tie-2-with-pharmabcine-300020495.html October 10, 2017
http://prnewswire.com/news-releases/3sbio-signs-exclusive-patent-license-agreement-with-dinona-for-leukotuximab-270411351.html April 4, 2015
http://prnewswire.com/news-releases/3sbios-peg-irinotecan-wins-ind-approval-from-china-fda-300231528.html March 3, 2017
Show more results
5 more results for 3sbio.com. Sign up or log in to access the full and uncovered results.

Add the leading solution to find professional email addresses to your toolkit.

Hunter is already trusted by more than 1,000,000 professionals to build more connections and grow their business. Start today and get 100 free searches/month..

Google
IBM
Microsoft
Shopify
Adobe
Oracle

More information about 3sbio.com

Language of the website: Norwegian